相关实验视频

Updated: Jun 7, 2025

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Isolation and Th17 Differentiation of Naïve CD4 T Lymphocytes

Published on: September 26, 2013

赛马福林5A通过PI3K-Akt-mTOR在全身性红斑狼中促进Th17的分化

Xin Chen^1,2, Lingjiang Zhu¹, Jieying Xu¹

¹Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310000, China.

Arthritis research & therapy

|November 20, 2024

概括

系统性红斑狼 (SLE) 患者表现出高血红素5A (Sema5A) 的水平,该血红素通过Sema5A-PlexinA1轴促进Th17细胞分化. 这一途径表明Sema5A是SLE的潜在治疗标.

科学领域:

免疫学免疫学免疫学
细胞生物学细胞生物学
分子医学是分子医学.

背景情况:

血清血红素5A (Sema5A) 在全身性红斑狼 (SLE) 中升高,与疾病活性相关.
之前的研究表明,与健康对照组 (HC) 相比,SLE患者的Sema5A增加.

研究的目的:

调查Sema5A在促进SLE中T助手17 (Th17) 细胞分化中的作用.
阐明Sema5A在SLE发病过程中的功能背后的分子机制.

主要方法:

使用ELISA进行量化的Sema5A,细胞因子 (IFN-γ,IL-4,IL-17A,IL-10).
在外周血液单核细胞 (PBMC) 中通过qRT-PCR和西部Blot测量了PlexinA1和PlexinB3的表达.
使用流细胞计分析了Th细胞子集,并研究了Sema5A在体外对CD4+T细胞分化的影响.

主要成果:

干白素-17A (IL-17A) 在SLE患者中升高,与Sema5A水平呈正相关.
塞马5A治疗诱导了Th17细胞分化,上调了RORγt,但没有影响Th1/Th2倾斜.
确定了Sema5A-PlexinA1轴作为一个关键的调解器,通过PI3K/Akt/mTOR信号通路促进Th17的分化.

结论:

在SLE中,Sema5A-PlexinA1轴是Th17细胞分化的关键媒介.
塞马5A代表了一种潜在的新型治疗点,用于管理SLE.
准Sema5A-PlexinA1通路可能为SLE治疗提供一个新的策略.

更多相关视频

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation

Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation

Published on: October 25, 2024

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

相关概念视频

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

TGF - β Signaling Pathway

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...